摘要
Dysregulated HGF/c-Met signalling has been associated with many human cancers,poor clinical outcomes,and even resistance acquisition to some approved targeted therapies.As such,c-Met kinase has emerged as an attractive target for anticancer drug discovery.
基金
This work was supported by the Fundamental Research Funds for the Central Universities(Nos.31920170193 and 31920200026).
